Cangene, Akzo Nobel Pharma International, F. Hoffmann La-Roche deal

CNJ (Toronto) will escrow C$1 million as its share of potential costs in a threatened legal action by Roche against Akzo's HIV kits, which use CNJ's nucleic acid sequencing based amplification (NASBA) technology (see BioCentury Sept. 25). ...